LGD-2226
An experimental SARM for muscle wasting and osteoporosis research.
Overview
LGD-2226 is an oral SARM targeting muscle wasting and osteoporosis, boosting bone density, stamina, and lean muscle with reduced prostate impact. It mimics testosterone for hypertrophy and endurance without excessive virilization. Used in fitness and age-related decline protocols.
Synonyms: 6-[Bis(2,2,2-trifluoroethyl)amino]-4-(trifluoromethyl)-2(1H)-quinolinone; LGD-2226(LGD2226); 2(1H)-Quinolinone,6-[bis(2,2,2-trifluoroethyl)amino]-4-(trifluoromethyl)-; 6-[bis(2,2,2-trifluoroethyl)amino]-4-(trifluoromethyl)-1H-quinolin-2-one; 6-[Bis(2,2,2-trifluoroethyl)amino]-4-(trifluoromethyl)-2(1H)-quinolinone
EINECS: 251-228-4
Product Categories: Export SARM series; nutritional fortifiers; pharmaceutical raw materials; SARM series
Mol File: 328947-93-9.mol
Physicochemical Properties
Melting point: 187-190°C
Boiling point: 364.4±42.0°C(Predicted)
Density: 1.526±0.06g/cm3(Predicted)
Storage temp.: -20°C Freezer, Under inert atmosphere
Solubility: DMSO (Slightly), Methanol (Slightly)
Form: Solid
Color: Pale Yellow to Light Yellow
MSDS Information
Experimental Data
1.Cell Experiment
Solubility in DMSO: 125 mg/mL (318.70 mM; assisted by sonication; hygroscopic DMSO significantly affects the solubility of the product, please use freshly opened DMSO)
Preparing Stock Solutions:
Please select an appropriate solvent to prepare the stock solution based on the product's solubility in different solvents; once the solution is prepared, aliquot and store it to avoid product degradation caused by repeated freeze-thaw cycles.
Storage conditions and duration for the stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, use within 6 months; when stored at -20°C, use within 1 month.
Pharmacodynamics
Mechanism Of Action
Similar Products
LGD-3303
Therapy
: Musculoskeletal diseases
Target
:
CAS
: 1196133-39-7 / 917891-35-1
MF
: C16H14ClF3N2O
MW
: 342.7433696
LY2452473
Therapy
: Musculoskeletal diseases
Target
: AR; PDE5A
CAS
: 1029692-15-6
MF
: C22H22N4O2
MW
: 374.44
AC-262536
Therapy
: Musculoskeletal diseases
Target
:
CAS
: 870888-46-3
MF
: C18H18N2O
MW
: 278.36
AC-262,356
Therapy
: Musculoskeletal diseases
Target
:
CAS
: 871032-12-1
MF
: C18H18N2O
MW
: 278.36